Antigenic variation in malaria  by Borst, Piet et al.
Cell, Vol. 82, 1-4, July 14, 1995, Copyright 0 1995 by Cell Press 
Antigenic Variation in Malaria Minireview 
Piet Borat, Wilbert Bitter, Richard McCulloch, 
Fred Van Leeuwen, and Gloria Rudenko 
The Netherlands Cancer Institute 
Division of Molecular Biology 
Plesmanlaan 121 
1066 CX Amsterdam 
The Netherlands 
Parasite variability is a major factor in parasite survival 
strategies. Some parasites rely on random mutations to 
create variation, and if the mutation rate is high, as in HIV, 
this may suffice to create unsurmountable difficulties for 
the host. Other parasites augment variability by regularly 
replacing the antigens exposed to the host immune sys- 
tem. African trypanosomes (sleeping sickness) and Neis- 
seria gonorrhoeae (gonorrhea) are prime examples of this 
antigenic variation in the strict sense (Borst, 1991; Borst 
and Rudenko, 1994; Dybrig, 1993). 
Since 1965, insiders have been aware of indications 
(Brown and Brown, 1965) that malaria parasites also use 
antigenic variation in the strict sense to escape host de- 
struction. As the proteins involved had never been fully 
characterized and as the genes coding for these variant 
antigens escaped cloning, the evidence for antigenic vari- 
ation did not seem compelling to outsiders or even to the 
insiders who write textbooks (Cox, 1993). The three papers 
published in this issue of Ce//(Baruch et al., 1995; Smith 
et al., 1995; Su et al., 1995) should serve to dispel this 
doubt. Together, these papers establish that malaria para- 
sites contain a large family of genes for variant antigens 
and that the differential expression of these genes helps 
the parasite to escape the host immune response. 
The variant antigens of malaria parasites discussed 
here are not on the surface of the parasite itself, but on 
the surface of the cell in which Plasmodium falciparum 
multiplies, the erythrocyte (Miller et al., 1994; Pasloske 
and Howard, 1994). The antigens reside in large proteins 
(200-350 kDa) collectively known as PfEMPl (for P. falci- 
parum-infected erythrocyte membrane protein 1). These 
proteins are secreted by the parasite and find their way 
into the erythrocyte membrane, where they are concen- 
trated in structures known as knobs (Figure 1). These 
knobs are only found in infected erythrocytes, and they 
are mainly composed of P. falciparum proteins other than 
PfEMPl (Berendt et al., 1994). 
Why would a parasite hiding safely in an erythrocyte, a 
cell unable to present antigen, reveal its presence to the 
host immune system by inserting its proteins into the host 
cell membrane? This seemingly suicidal action appears 
to be required to avoid another death trap, the host spleen. 
The reticuloendothelial system of the spleen is able to spot 
damaged erythrocytes and remove them from circulation. 
When malaria parasites divide rapidly in the erythrocyte, 
they damage their host cell. The spleen can sense the 
damage, and the parasites perish in the endocytosed 
erythrocyte, together with their sickly host cell. To avoid 
splenic death, P. falciparum modifies the host cell by in- 
serting PfEMPl. These proteins make the erythrocyte at- 
tach to vascular endothelium, resulting in their retention 
invascular beds. Onlyerythrocytes infected with immature 
parasites circulate in the bloodstream. Although this trick 
allows the parasite to avoid splenic death, it now becomes 
vulnerable to immune attack. Plasmodium uses antigenic 
variation of PfEMPl to mitigate the consequences of this 
attack. 
Evidence that PfEMPl is remarkably variable has been 
accumulating for 30 years (Miller et al., 1994; Pasloske 
and Howard, 1994). This antigenic diversity is correlated 
with functional diversity. Different populations of infected 
erythrocytes may adhere to a variety of endothelial recep- 
tors, including vascular cell adhesion molecule 1 (VCAM-l), 
intercellular adhesion molecule 1 (ICAM-l), CD36, E-selec- 
tin (also known as endothelial leukocyte adhesion mole- 
cule 1, or ELAM-l), and the extracellular matrix protein 
thrombospondin (TSP), all proteins involved in adhesion 
of host leukocytes or platelets to endothelium. Obviously, 
the structures allowing different PfEMPl proteins to ad- 
here to these receptors must also be quite diverse. 
The two teams that found the gene family encoding 
PfEMPl used different approaches that proved to be 
in part complementary. The Wellems-Miller-NewboId- 
Ravetch team (Smith et al., 1995; Suet al., 1995) stumbled 
on the gene family during a chromosome walk that was 
started by Wellems and coworkers to find the genetic locus 
involved in resistance of P. falciparum to chloroquine. By 
genetic methods, this locus had been positioned in a seg- 
ment of chromosome 7. When Su et al. (1995) tried to find 
the drug resistance gene, they fortuitously discovered a 
number of adjacent genes that looked like genes encoding 
members of the PfEMPl family. They call these genes var 
genes (see Table 1 for nomenclature). The other team, 
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Figure 1. P. falciparum-Infected Erythrocyte 
P. falciparum-infected erythrocytes express on the surface of the 
erythrocyle a variant antigen from the PfEMPl family, which plays an 
important role in survival of the infected cell by mediating attachment 
lo the vascular endothelium. See text for details. 




P. falciparum-infected erythrocyte 
membrane protein 
Description 
A family of proteins secreted by P. falciparum within an infected 
erythrocyte that migrate to knob structures on the erythrocyte 
surface. These function as erythmcyte receptors for 
endothelial ceils and are encoded by ver genes. 
var genes Large family of highly variant genes containing 
conserved DBL domains 
Genes encoding proteins such as PfEMP-1 that function as 
erythrocyte receptors for various cell surface molecules 
present on endothelial cells. Differential expression results in 
antigenic variation. 
DABP Duffy antigen-binding protein Proteins of P. vivax and P. knowlesi that bind an erythrocyte 
surface receptor (Duffy antigen) during parasite invasion. 
EBA-175 Erythrocyte-binding protein Protein of P. falciparum (analogous to DABP) that binds an 
erythrocyte surface molecule (sialic acid) during parasite 
invasion. 
led by R. Howard (Baruch et al., 1995) used an antiserum 
directed against one member of the PfEMPl familyto iden- 
tify a fragment of the corresponding gene in a DNA expres- 
sion library. Getting a full-length cDNA clone proved dif- 
ficult, however. Plasmodium switches at a high rate 
between members of the PfEMPl family, and populations 
of infected erythrocytes are therefore always heteroge- 
neous in PfEMPl mRNA. They finally identified overlap- 
ping cDNA sequences from one parasite strain that en- 
code two versions of PfEMPl . 
What is the evidence that the var genes cloned by these 
two groups code for PfEMPl and that PfEMPl undergoes 
antigenic variation in the strict sense? The results pre- 
sented by Baruch et al. (1995) are relatively straightfor- 
ward, as they focused primarily on one member of the 
PfEMPl family, produced by the Malayan Camp (MC) line 
of Plasmodium. This MC PfEMPl mediates binding of in- 
fected erythrocytes to a surface receptor of endothelial 
cells, CD36, and to TSP, but not to other receptors, such 
as ICAM-1. Baruch et al. (1995) have used fusion proteins 
made with fragments of their cDNA to make antisera 
against segments of the MC PfEMPl. These antisera spe- 
cifically detect PfEMPl in the knobs of erythrocytes in- 
fected with the MC line of Plasmodium, and they block 
binding of the infected erythrocyte to endothelial recep- 
tors. Baruch et al. (1995) also show that the MC PfEMPl 
is a member of a large family of related surface proteins 
that differ in antigenic and adhesion properties. 
Su et al. (1995) have sequenced four genes of the var 
family. The deduced protein sequences look like cellular 
adhesion molecules; i.e., they appear to consist of a large 
and variable extracellular domain, a single transmem- 
brane segment, and a conserved intracellular domain. As 
expected for a variant antigen, the extracellular domains 
of different members of the family are very different in 
sequence, although they share an overall similarity in 
structure. 
Evidence for the differential expression of the members 
of the var family in different parasite lines can be found 
in all three papers (Baruch et al., 1995; Smith et al., 1995; 
Su et al., 1995) but the most extensive analyses are pre- 
sented by Smith et al. (1995). As the rate of switching is 
as high as 2.4% per generation (Smith et al., 1995) it is 
impossible to obtain large populations of parasites only 
expressing asingle vargene. The problem is compounded 
by the extensive homology among different var genes, 
making gene-specific probes hard to obtain. Smith et al. 
(1995) analyzed a series of Plasmodium clones that differ 
in antigenic and cytoadhesive properties and find that in 
some cases, specific vaf transcripts were virtually unique 
to the clones from which they were derived. This shows 
that the differential control of vaf gene expression must 
be tight, implying that a single infected erythrocyte may 
only express one or at most a few var genes. This is in 
agreement with the previous work on the adhesive and 
antigenic properties of infected erythrocytes. Su et al. 
(1995) studied the transcription of three vaf genes in differ- 
ent Plasmodium clones. No transcripts were found for two 
of the genes in any of the clones, whereas one gene was 
expressed in one parasite clone, but not in two others. 
Taken together, these analyses establish that var genes 
are differentially expressed and that differential expres- 
sion is linked to antigenic variation of the adhesive protein 
PfEMPl on the erythrocyte surface. 
In large families, it is often difficult to get a head count, 
especially when some heads look rather different. The var 
gene family has at least 50 members, and although some 
of the genes are clustered (Su et al., 1995), the members 
are scattered over most if not all malaria chromosomes 
(Peterson et al., 1995; Su et al., 1995). An upper limit 
estimate (Su et al., 1995) gives 150 members. Since the 
genes are large, this would correspond to 6% of the ma- 
laria genome. Which fraction of these genes is functional 
is not known. As the available evidence suggests that the 
family evolves at a very high rate, one can expect a sub- 
stantial fraction of the family members to be nonfunctional. 
The adhesion function of the PfEMPl proteins may have 
evolved from other adhesion proteins required for Plasmo- 
dium toget intoerythrocytes. Suet al. (1995) stressthat the 
var gene products are related to the erythrocyte-binding 
protein EBA-175 of P. falciparum (Sim et al., 1994) and 
to the Duffy antigen-binding proteins (DABPs) of P. vivax 
and P. knowlesi. The singlecopy genes for EBA-175 and 
DABP are conserved and present in all Plasmodium lines. 
The common motifs in eba-775 and var gene products 
may indicate a common origin and have led Suet al. (1995) 
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to group the proteins in one superfamily of Duffy binding- 
like (DBL) proteins. 
With the var genes in hand, the interesting biological 
questions can now be tackled. How does Plasmodium 
switch the antigen produced? How do the PfEMPl genes 
evolve so rapidly? How does PfEMPl get from the place 
of synthesis in the parasite to its correct position in the 
knobs of the erythrocyte membrane? Thus far, there are 
only some data bearing on the first question, the mecha- 
nism of switching. 
The analysis of antigenic variation in other organisms 
has delineated three basic mechanisms for switching in 
large families of surface antigens (Borst, 1991). The first 
mechanism is the pretranscriptional, e.g., the replacement 
of the antigen gene transcribed. This can be done by gene 
conversion or by reciprocal recombination. The promoter 
remains unaltered. The second mechanism is transcrip- 
tional, e.g., the activation of the promoter of a silent gene 
and the switching off of the promoter of the previously 
active antigen gene. This is one of the switching modes 
used by African trypanosomes, but the mechanism re- 
mains unresolved (Borst and Rudenko, 1994). The third 
mechanism is posttranscriptional, e.g., changing the read- 
ing frame of antigen mRNAs. An example is the Opa pro- 
teins, minor surface proteins of Neisseria species. The opa 
genes contain CTCTT repeats in their signal sequence. 
Depending on the copy number of these repeats, the 
mRNA will either be translated into full-length protein or 
into a truncated N-terminal fragment. Variations in copy 
number probably result from slipped mispairing during 
DNA replication (Borst, 1991). 
The limited data now available suggest that Plasmodium 
does not simply imitate African trypanosomes in its switch- 
ing mechanism. Expressed PfEMPl genes are not invari- 
ably located in telomeric expression sites, as are the VSG 
(for variant-specific surface glycoprotein) genes of try- 
panosomes (Borst, 1991; Borst and Rudenko, 1994). 
There are also no indications for activation of silent var 
genes by duplicative transposition into an expression site. 
This indicates that Plasmodium must either transfer var 
genes into expression sites by a nonduplicative mecha- 
nism (e.g., reciprocal recombination) or control the large 
var gene family by transcriptional or posttranscriptional 
mechanisms. An intriguing finding is the presence of a 
large amount of a very heterogeneous transcript of about 
2 kb that is related to the 3’ half of the var genes. The 
authors speculate that this transcript is involved in recom- 
bination processes required for switching. Another specu- 
lative possibility is that Plasmodium transcribes all var 
genes all the time, but controls expression at the level of 
RNA processing by partial degradation of all mRNAs but 
one. Nuclear run-on experiments should allow the Wel- 
lems group to test this. Differential RNAdegradation would 
be a novel mechanism for switching the protein made in 
antigenic variation. Admittedly this would be wasteful, but 
antigenic variation is an intrinsically wasteful survival strat- 
egy anyhow, and degrading excess mRNAs is less waste- 
ful than the posttranscriptional mechanism used by Neis- 
seria to control its opa genes (Borst, 1991). 
Although antigenic variation looks like a perfect way for 
a parasite to elude the murderous immune system of its 
host, the strategy is far from simple in practice (Borst, 
1991). Obviously, the parasite has to maintain a sizeable 
repertoire of variant antigens and the ability to switch at 
appropriate rates the variant antigen produced. Less obvi- 
ous, but equally important, the parasite also has to avoid 
gross population heterogeneity during a chronic infection. 
If each parasite in the population were to express a differ- 
ent var gene, then the complete repertoire would be ex- 
pressed at all times, and antigenic variation would not 
work. In African trypanosomes, the order of expression 
of variant antigen genes seems to be determined by a 
complex combination of genetic and epigenetic factors, 
and it will be of interest to see how Plasmodium solves 
this vexing problem. 
Is the var gene family the only source of antigenic varia- 
tion in Plasmodium? Once an organism starts on this strat- 
egy, it may become a specialist. In Neisseria bacteria, 
there are at least two types of surface protein indepen- 
dently undergoing antigenic variation (Borst, 1991). In try- 
panosomes, there is suggestive evidence for antigenic 
variation of receptors involved in food uptake, in addition 
to antigenic variation of the main component of the surface 
coat, VSG (Borst and Rudenko, 1994). It will be interesting 
to test whether antigenicvariation in Plasmodium will also 
extend to proteins exposed on the surface of the parasite 
itself. 
One always hopes that a breakthrough in the under- 
standing of parasite biochemistry will be translatable into 
better control of parasitic disease, and there is some basis 
for this hope in the case of the var genes. The ability of 
P. falciparum to make PfEMPl correlates with virulence. 
Sequestration of infected erythrocytes in brain capillaries 
is considered a prerequisite for cerebral malaria, a lethal 
complication of P. falciparum infection. This sequestration 
is dependent on PfEMPl in the knobs on the erythrocyte 
surface. If one could prevent PfEMPl from gluing the 
erythrocytes onto the vessel endothelium, the infected 
erythrocytes would be flushed out toward the spleen and 
destroyed. Precise knowledge of the vaf gene family may 
allow the generation of vaccines that protect against the 
major classes of adhesion molecules that the parasite can 
produce. As the receptors on endothelial cells recognized 
by these adhesion molecules are limited, the parasite is 
also limited in the variability of the adhesion molecules it 
can produce. Time will tell whether this approach is feasi- 
ble and useful. 
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